Jeffrey Robert Ajer's Net Worth

Jeffrey Robert Ajer's net worth is estimated to be at least $18,353,573.58 as of 11/22/2024. CoreStreet's estimation of Jeffrey Robert Ajer's net worth is based on their sale of stock and current holding of stock.

Jeffrey Robert Ajer is EVP at Biomarin Pharmaceutical Inc. They have executed at least 48 trades of stock as per SEC Form 4 filings. Their most recent trade was for 4,000 units of BMRN stock on 03/05/2024. Their biggest sale was on 01/25/2023 when they sold 49,000 units of Biomarin Pharmaceutical Inc stock for $5,669,300.00. They typically trade 4 times per year.

Total value of insider buys:
  • $0.00
Total value of insider sells:
  • $18,353,573.58
Most recent insider trade:
  • March 5, 2024

Jeffrey Robert Ajer's Insider Trading History

Biomarin Pharmaceutical IncTitleAmountPriceTypeTotal Value
March 5, 2024
EVP4,000$87.07Sell$348,280.00
Aug. 16, 2023
EVP5,000$90.00Sell$450,000.00
Jan. 25, 2023
EVP49,000$115.70Sell$5,669,300.00
Nov. 2, 2022
EVP3,000$86.12Sell$258,360.00
Aug. 11, 2022
EVP3,000$95.62Sell$286,860.00
May 26, 2022
EVP1,308$78.94Sell$103,253.52
April 13, 2022
EVP1,180$82.47Sell$97,314.60
March 29, 2022
EVP1,618$79.43Sell$128,517.74
March 23, 2022
EVP6,129$81.78Sell$501,229.62
Oct. 26, 2021
EVP2,739$73.60Sell$201,590.40
April 8, 2021
EVP1,537$78.81Sell$121,130.97
March 24, 2021
EVP1,181$76.30Sell$90,110.30
March 18, 2021
EVP1,308$77.99Sell$102,010.92
Oct. 14, 2020
EVP2,121$79.91Sell$169,489.11
June 19, 2020
EVP15,000$124.00Sell$1,860,000.00
April 8, 2020
EVP2,407$79.98Sell$192,511.86
April 1, 2020
EVP1,537$82.00Sell$126,034.00
March 24, 2020
EVP2,041$74.36Sell$151,768.76
March 21, 2019
EVP4,519$89.98Sell$406,619.62
March 19, 2019
EVP3,728$93.07Sell$346,964.96
Nov. 14, 2018
EVP9,000$92.15Sell$829,350.00
Oct. 3, 2018
EVP1,000$98.98Sell$98,980.00
June 11, 2018
EVP1,436$90.31Sell$129,685.16
May 7, 2018
EVP309$85.96Sell$26,561.64
April 2, 2018
EVP2,119$80.12Sell$169,774.28
March 29, 2018
EVP1,537$79.69Sell$122,483.53
March 21, 2018
EVP4,368$83.90Sell$366,475.20
March 9, 2018
EVP2,972$82.39Sell$244,863.08
Sept. 22, 2017
EVP3,521$95.00Sell$334,495.00
June 7, 2017
EVP1,004$89.61Sell$89,968.44
May 2, 2017
EVP302$96.74Sell$29,215.48
March 29, 2017
EVP3,890$89.15Sell$346,793.50
March 7, 2017
EVP5,000$90.56Sell$452,800.00
Sept. 27, 2016
EVP18,467$95.61Sell$1,765,629.87
May 3, 2016
EVP415$86.03Sell$35,702.45
March 4, 2016
SVP1,255$88.42Sell$110,967.10
July 20, 2015
SVP3,000$150.00Sell$450,000.00
June 4, 2015
SVP1,362$122.35Sell$166,640.70
June 1, 2015
SVP377$123.76Sell$46,657.52
May 26, 2015
SVP1,625$126.55Sell$205,643.75
Nov. 3, 2014
SVP47$83.54Sell$3,926.38
May 16, 2014
SVP1,004$56.91Sell$57,137.64
May 13, 2013
SVP1,248$69.26Sell$86,436.48
Nektar TherapeuticsTitleAmountPriceTypeTotal Value
Sept. 28, 2020
Director3,250$17.25Sell$56,062.50
Sept. 21, 2020
Director2,250$19.74Sell$44,415.00
Sept. 30, 2019
Director2,375$18.06Sell$42,892.50
Sept. 20, 2019
Director2,250$20.24Sell$45,540.00
Sept. 20, 2018
Director6,750$56.76Sell$383,130.00